Literature DB >> 10699316

Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules.

C J Provoda1, K D Lee.   

Abstract

Advances in our understanding of fundamental cell biological processes have facilitated an expansion of therapeutic approaches to altering cellular physiology and phenotype. As many of these methods involve macromolecular agents that act on targets within the nucleus or cytoplasm, achieving their full potential ultimately requires the efficient delivery of these agents across the cell membrane barrier into the cytosol. Various strategies have been employed to enhance cytosolic delivery. These include either directly penetrating the plasma membrane, or avoiding degradation within the hydrolytic environment of the endosomal/lysosomal pathway after endocytic uptake. Some of the more promising methods in this regard have exploited the mechanisms utilized by certain viruses and bacteria for escaping into their host cell's cytosol. In this review, we will discuss some of these methods with an emphasis on the use of pore-forming proteins from bacteria. Particular attention will be drawn to the pH-sensitive endosomolytic bacterial hemolysins, such as listeriolysin O, and the potentiol for their use in cytosolic drug delivery systems.

Mesh:

Substances:

Year:  2000        PMID: 10699316     DOI: 10.1016/s0169-409x(99)00067-8

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  16 in total

Review 1.  Applications of biological pores in nanomedicine, sensing, and nanoelectronics.

Authors:  Sheereen Majd; Erik C Yusko; Yazan N Billeh; Michael X Macrae; Jerry Yang; Michael Mayer
Journal:  Curr Opin Biotechnol       Date:  2010-06-18       Impact factor: 9.740

2.  Contribution of Lysinibacillus sphaericus hemolysin and chitin-binding protein in entomopathogenic activity against insecticide resistant Aedes aegypti.

Authors:  Paula Andrea Rojas-Pinzón; Jenny Dussán
Journal:  World J Microbiol Biotechnol       Date:  2017-09-22       Impact factor: 3.312

3.  Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.

Authors:  Rady J Laborde; Oraly Sanchez-Ferras; María C Luzardo; Yoelys Cruz-Leal; Audry Fernández; Circe Mesa; Liliana Oliver; Liem Canet; Liane Abreu-Butin; Catarina V Nogueira; Mayra Tejuca; Fabiola Pazos; Carlos Álvarez; María E Alonso; Ieda M Longo-Maugéri; Michael N Starnbach; Darren E Higgins; Luis E Fernández; María E Lanio
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

4.  Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery.

Authors:  Nicole J Yang; David V Liu; Demetra Sklaviadis; Dan Y Gui; Matthew G Vander Heiden; K Dane Wittrup
Journal:  Mol Pharm       Date:  2015-05-04       Impact factor: 4.939

5.  Targeting and blocking B7 costimulatory molecules on antigen-presenting cells using CTLA4Ig-conjugated liposomes: in vitro characterization and in vivo factors affecting biodistribution.

Authors:  Chung-Gyu Park; Natalie W Thiex; Kyung-Mi Lee; Gregory L Szot; Jeffery A Bluestone; Kyung-Dall Lee
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

6.  Development of a mariner-based transposon and identification of Listeria monocytogenes determinants, including the peptidyl-prolyl isomerase PrsA2, that contribute to its hemolytic phenotype.

Authors:  Jason Zemansky; Benjamin C Kline; Joshua J Woodward; Jess H Leber; Hélène Marquis; Daniel A Portnoy
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

7.  Gold nanoparticles delivery in mammalian live cells: a critical review.

Authors:  Raphaël Lévy; Umbreen Shaheen; Yann Cesbron; Violaine Sée
Journal:  Nano Rev       Date:  2010-02-22

8.  Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.

Authors:  Na Hyung Kim; Chester Provoda; Kyung-Dall Lee
Journal:  Mol Pharm       Date:  2015-01-22       Impact factor: 4.939

Review 9.  Biotechnological applications of Listeria's sophisticated infection strategies.

Authors:  Sukhadeo Barbuddhe; Trinad Chakraborty
Journal:  Microb Biotechnol       Date:  2008-06-09       Impact factor: 5.813

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.